A Study on Estimated Risks of Certain Adverse Events in Adults With Von Willebrand Disease (VWD) Treated With Veyvondi

Study of Voncento® in Subjects With Von Willebrand Disease

NCT02552576 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease

NCT00816660 ·Status: COMPLETED ·Phase: PHASE1

A Study on the Outcomes of Recombinant Von Willebrand Factor on Demand Treatment and Prevention and Treatment of Bleeding During and After Surgery in Adults With Inherited Von Willebrand Disease in the United Kingdom (UK)

NCT06433778 ·Status: COMPLETED

rVWF IN PROPHYLAXIS

NCT02973087 ·Status: COMPLETED ·Phase: PHASE3

Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery

NCT02283268 ·Status: COMPLETED ·Phase: PHASE3

Type 3 Von Willebrand International Registries Inhibitor Prospective Study

NCT02460458 ·Status: COMPLETED

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

NCT01410227 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

NCT06998524 ·Status: RECRUITING ·Phase: PHASE3

Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding

NCT02792205 ·Status: COMPLETED

ATHN 9: Severe VWD Natural History Study

NCT03853486 ·Status: ACTIVE_NOT_RECRUITING

A Study of Bleeding and Treatment in Participants With Von Willebrand Disease

NCT06610201 ·Status: RECRUITING

To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)

NCT04770935 ·Status: COMPLETED ·Phase: PHASE1

A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)

NCT07129343 ·Status: RECRUITING ·Phase: PHASE3

Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)

NCT00630448 ·Status: WITHDRAWN

Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B

NCT03855280 ·Status: COMPLETED ·Phase: PHASE3

A Study Assessing HMB-002 in Participants With Von Willebrand Disease

NCT06754852 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)

NCT02466789 ·Status: COMPLETED

Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia

NCT01439971 ·Status: COMPLETED ·Phase: PHASE1

Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)

NCT00168090 ·Status: COMPLETED ·Phase: PHASE4

National Study of Moderate and Severe Von Willebrand Disease in the Netherlands

NCT00510042 ·Status: COMPLETED

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)

NCT05776069 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Minimize Menorrhagia in Women With Von Willebrand Disease

NCT02606045 ·Status: TERMINATED ·Phase: PHASE3

Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease

NCT00004667 ·Status: COMPLETED ·Phase: PHASE1

Registry of Patients With Von WilLEbrand Disease Treated With Voncento®

NCT04657887 ·Status: COMPLETED

Recombinant vWF Concentrate and ECMO

NCT06118372 ·Status: RECRUITING ·Phase: PHASE1